Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 54 | 2023 | 327 | 16.400 |
Why?
|
Substance-Related Disorders | 70 | 2023 | 608 | 12.280 |
Why?
|
Buprenorphine | 23 | 2022 | 130 | 8.090 |
Why?
|
Narcotic Antagonists | 24 | 2022 | 91 | 7.170 |
Why?
|
Substance Abuse Treatment Centers | 32 | 2019 | 92 | 7.130 |
Why?
|
Naltrexone | 19 | 2020 | 60 | 6.020 |
Why?
|
Opiate Substitution Treatment | 23 | 2022 | 125 | 5.510 |
Why?
|
Drug Overdose | 13 | 2023 | 93 | 4.910 |
Why?
|
Prisoners | 26 | 2023 | 119 | 4.860 |
Why?
|
Alcoholism | 20 | 2022 | 253 | 4.470 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2019 | 41 | 3.680 |
Why?
|
Methadone | 22 | 2023 | 86 | 3.200 |
Why?
|
Medicaid | 8 | 2019 | 286 | 3.090 |
Why?
|
Humans | 225 | 2023 | 49675 | 2.690 |
Why?
|
Analgesics, Opioid | 13 | 2023 | 356 | 2.610 |
Why?
|
Health Services Accessibility | 10 | 2020 | 449 | 2.580 |
Why?
|
Criminal Law | 9 | 2018 | 76 | 2.550 |
Why?
|
Substance Abuse, Intravenous | 20 | 2023 | 57 | 2.460 |
Why?
|
United States | 65 | 2020 | 6234 | 2.430 |
Why?
|
Insurance Coverage | 7 | 2019 | 96 | 2.410 |
Why?
|
HIV Infections | 16 | 2023 | 898 | 2.400 |
Why?
|
Adult | 103 | 2023 | 13334 | 2.060 |
Why?
|
Health Policy | 4 | 2019 | 163 | 1.880 |
Why?
|
Alcohol Drinking | 10 | 2022 | 265 | 1.880 |
Why?
|
Male | 131 | 2021 | 23140 | 1.830 |
Why?
|
Patient Acceptance of Health Care | 8 | 2019 | 415 | 1.820 |
Why?
|
Female | 128 | 2023 | 26343 | 1.810 |
Why?
|
Patient-Centered Care | 4 | 2020 | 225 | 1.810 |
Why?
|
Neonatal Abstinence Syndrome | 4 | 2020 | 30 | 1.780 |
Why?
|
Prisons | 10 | 2016 | 83 | 1.770 |
Why?
|
Ambulatory Care | 11 | 2021 | 268 | 1.720 |
Why?
|
Delayed-Action Preparations | 10 | 2020 | 103 | 1.700 |
Why?
|
Primary Health Care | 13 | 2017 | 569 | 1.640 |
Why?
|
Emergency Service, Hospital | 8 | 2019 | 787 | 1.590 |
Why?
|
Criminals | 7 | 2018 | 46 | 1.530 |
Why?
|
Secondary Prevention | 9 | 2017 | 127 | 1.480 |
Why?
|
State Government | 3 | 2019 | 32 | 1.460 |
Why?
|
Narcotics | 7 | 2012 | 45 | 1.380 |
Why?
|
Continuity of Patient Care | 5 | 2017 | 166 | 1.340 |
Why?
|
Delivery of Health Care, Integrated | 5 | 2015 | 104 | 1.330 |
Why?
|
Cataract Extraction | 3 | 2011 | 29 | 1.220 |
Why?
|
Middle Aged | 60 | 2022 | 13451 | 1.130 |
Why?
|
Postoperative Complications | 8 | 2011 | 881 | 1.130 |
Why?
|
Mass Screening | 9 | 2021 | 549 | 1.110 |
Why?
|
Medication Adherence | 2 | 2017 | 249 | 1.100 |
Why?
|
Delivery of Health Care | 4 | 2020 | 341 | 1.090 |
Why?
|
Practice Patterns, Physicians' | 6 | 2022 | 680 | 1.050 |
Why?
|
Recidivism | 2 | 2022 | 18 | 1.050 |
Why?
|
Mothers | 6 | 2023 | 231 | 1.040 |
Why?
|
Behavior, Addictive | 3 | 2014 | 76 | 1.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2016 | 714 | 1.010 |
Why?
|
Rural Population | 3 | 2020 | 161 | 1.010 |
Why?
|
Hepatitis C | 3 | 2023 | 129 | 0.970 |
Why?
|
Early Medical Intervention | 2 | 2020 | 14 | 0.960 |
Why?
|
Health Services Needs and Demand | 9 | 2015 | 198 | 0.960 |
Why?
|
Sexual Partners | 5 | 2013 | 96 | 0.950 |
Why?
|
Behavior Therapy | 3 | 2016 | 162 | 0.950 |
Why?
|
Pharmacies | 1 | 2023 | 26 | 0.950 |
Why?
|
Referral and Consultation | 7 | 2019 | 357 | 0.940 |
Why?
|
Inservice Training | 2 | 2017 | 71 | 0.890 |
Why?
|
Population Surveillance | 3 | 2019 | 204 | 0.890 |
Why?
|
Injections, Intramuscular | 6 | 2020 | 68 | 0.880 |
Why?
|
Smoking Cessation | 7 | 2016 | 557 | 0.870 |
Why?
|
Drug Monitoring | 2 | 2012 | 96 | 0.850 |
Why?
|
Substance Abuse Detection | 5 | 2009 | 33 | 0.840 |
Why?
|
Surveys and Questionnaires | 22 | 2021 | 2287 | 0.830 |
Why?
|
Intimate Partner Violence | 1 | 2021 | 24 | 0.830 |
Why?
|
Counseling | 7 | 2021 | 389 | 0.820 |
Why?
|
Tobacco Use Disorder | 4 | 2014 | 240 | 0.820 |
Why?
|
Intraoperative Complications | 2 | 2011 | 52 | 0.820 |
Why?
|
Needle-Exchange Programs | 6 | 2023 | 7 | 0.810 |
Why?
|
Sleep Wake Disorders | 3 | 2008 | 64 | 0.800 |
Why?
|
Parents | 2 | 2023 | 311 | 0.800 |
Why?
|
Interinstitutional Relations | 2 | 2016 | 43 | 0.790 |
Why?
|
Alcohol-Related Disorders | 3 | 2021 | 29 | 0.790 |
Why?
|
Massachusetts | 14 | 2022 | 2021 | 0.780 |
Why?
|
Veterans | 7 | 2014 | 553 | 0.760 |
Why?
|
Infant Health | 1 | 2019 | 2 | 0.760 |
Why?
|
Maternal Health | 1 | 2019 | 7 | 0.760 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 59 | 0.750 |
Why?
|
Healthcare Disparities | 2 | 2019 | 254 | 0.750 |
Why?
|
Practice Patterns, Nurses' | 1 | 2019 | 20 | 0.740 |
Why?
|
Surgical Procedures, Operative | 3 | 2012 | 128 | 0.740 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2019 | 3 | 0.730 |
Why?
|
Patient Dropouts | 5 | 2007 | 49 | 0.730 |
Why?
|
Financing, Government | 1 | 2019 | 31 | 0.730 |
Why?
|
Epidemics | 1 | 2019 | 27 | 0.730 |
Why?
|
Quality of Life | 5 | 2020 | 736 | 0.720 |
Why?
|
HIV Seropositivity | 7 | 2012 | 80 | 0.700 |
Why?
|
Attitude of Health Personnel | 5 | 2016 | 488 | 0.700 |
Why?
|
Community Health Services | 4 | 2016 | 127 | 0.690 |
Why?
|
Health Status | 5 | 2022 | 408 | 0.690 |
Why?
|
Aged | 39 | 2022 | 10870 | 0.670 |
Why?
|
Government Programs | 1 | 2017 | 19 | 0.670 |
Why?
|
Heroin Dependence | 5 | 2012 | 20 | 0.660 |
Why?
|
Fear | 2 | 2020 | 51 | 0.650 |
Why?
|
Models, Statistical | 3 | 2016 | 295 | 0.650 |
Why?
|
Quality Assurance, Health Care | 2 | 2016 | 229 | 0.630 |
Why?
|
Informed Consent | 5 | 2018 | 112 | 0.630 |
Why?
|
Patient Compliance | 7 | 2018 | 334 | 0.620 |
Why?
|
New England | 7 | 2023 | 244 | 0.620 |
Why?
|
Politics | 1 | 2017 | 24 | 0.620 |
Why?
|
Aged, 80 and over | 19 | 2021 | 4220 | 0.620 |
Why?
|
Retrospective Studies | 19 | 2019 | 4517 | 0.620 |
Why?
|
Public Health | 2 | 2017 | 147 | 0.610 |
Why?
|
Rhode Island | 9 | 2013 | 82 | 0.610 |
Why?
|
Law Enforcement | 2 | 2013 | 24 | 0.610 |
Why?
|
Cooperative Behavior | 3 | 2016 | 204 | 0.600 |
Why?
|
Pharmacists | 3 | 2013 | 97 | 0.600 |
Why?
|
Hospitalization | 6 | 2021 | 1093 | 0.600 |
Why?
|
Health Resources | 1 | 2016 | 73 | 0.600 |
Why?
|
Treatment Outcome | 17 | 2019 | 3888 | 0.590 |
Why?
|
Crime | 3 | 2012 | 52 | 0.590 |
Why?
|
Anti-Anxiety Agents | 2 | 2008 | 30 | 0.580 |
Why?
|
Cross-Sectional Studies | 17 | 2023 | 2125 | 0.580 |
Why?
|
Police | 1 | 2016 | 30 | 0.580 |
Why?
|
Qualitative Research | 5 | 2023 | 432 | 0.570 |
Why?
|
Hepatitis C, Chronic | 2 | 2013 | 74 | 0.570 |
Why?
|
Naloxone | 4 | 2022 | 39 | 0.560 |
Why?
|
Harm Reduction | 1 | 2015 | 14 | 0.560 |
Why?
|
Multivariate Analysis | 11 | 2019 | 836 | 0.560 |
Why?
|
Prescriptions | 1 | 2015 | 22 | 0.560 |
Why?
|
State Health Plans | 1 | 2015 | 11 | 0.560 |
Why?
|
Resource Allocation | 1 | 2015 | 19 | 0.560 |
Why?
|
Health Care Rationing | 1 | 2015 | 18 | 0.560 |
Why?
|
Sexual Behavior | 7 | 2013 | 191 | 0.550 |
Why?
|
Health Plan Implementation | 1 | 2015 | 39 | 0.550 |
Why?
|
Family Practice | 6 | 2005 | 194 | 0.540 |
Why?
|
Community Mental Health Services | 1 | 2016 | 81 | 0.540 |
Why?
|
Mental Health Services | 7 | 2020 | 277 | 0.540 |
Why?
|
Young Adult | 13 | 2022 | 3701 | 0.530 |
Why?
|
Longitudinal Studies | 9 | 2017 | 1042 | 0.530 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 78 | 0.530 |
Why?
|
Hindlimb | 4 | 2000 | 40 | 0.530 |
Why?
|
Mental Disorders | 7 | 2019 | 669 | 0.520 |
Why?
|
Evidence-Based Medicine | 3 | 2013 | 360 | 0.520 |
Why?
|
General Surgery | 4 | 2001 | 120 | 0.510 |
Why?
|
Blood Loss, Surgical | 2 | 2012 | 40 | 0.510 |
Why?
|
Directly Observed Therapy | 1 | 2013 | 5 | 0.500 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2000 | 15 | 0.500 |
Why?
|
HIV Seronegativity | 4 | 2002 | 19 | 0.500 |
Why?
|
Pharmaceutical Services | 2 | 2013 | 26 | 0.500 |
Why?
|
Needle Sharing | 5 | 2023 | 10 | 0.490 |
Why?
|
Patient Satisfaction | 3 | 2008 | 365 | 0.490 |
Why?
|
Blood Transfusion | 2 | 2012 | 126 | 0.490 |
Why?
|
Pilot Projects | 6 | 2022 | 753 | 0.480 |
Why?
|
Telemedicine | 1 | 2017 | 235 | 0.480 |
Why?
|
Prescription Drug Misuse | 1 | 2013 | 22 | 0.480 |
Why?
|
Cardiovascular Diseases | 7 | 2022 | 723 | 0.470 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2012 | 8 | 0.470 |
Why?
|
Infant | 5 | 2021 | 1389 | 0.470 |
Why?
|
Prospective Studies | 15 | 2020 | 2520 | 0.470 |
Why?
|
Internet | 2 | 2015 | 453 | 0.460 |
Why?
|
Needles | 1 | 2013 | 50 | 0.460 |
Why?
|
Length of Stay | 5 | 2007 | 627 | 0.460 |
Why?
|
Health Personnel | 1 | 2016 | 314 | 0.450 |
Why?
|
Data Collection | 8 | 2013 | 375 | 0.450 |
Why?
|
Age Factors | 5 | 2017 | 1410 | 0.440 |
Why?
|
Physicians, Family | 4 | 2008 | 69 | 0.440 |
Why?
|
Cohort Studies | 15 | 2012 | 2064 | 0.440 |
Why?
|
Sexually Transmitted Diseases | 1 | 2012 | 88 | 0.430 |
Why?
|
Hematocrit | 2 | 2010 | 36 | 0.430 |
Why?
|
Eye Diseases | 1 | 2011 | 35 | 0.410 |
Why?
|
Prescription Drugs | 1 | 2011 | 48 | 0.410 |
Why?
|
Comorbidity | 8 | 2019 | 1000 | 0.410 |
Why?
|
Chronic Disease | 3 | 2010 | 671 | 0.410 |
Why?
|
Pregnancy | 7 | 2021 | 2089 | 0.400 |
Why?
|
Rectal Neoplasms | 5 | 1996 | 74 | 0.400 |
Why?
|
Intraoperative Care | 1 | 2010 | 40 | 0.400 |
Why?
|
Logistic Models | 10 | 2019 | 1159 | 0.390 |
Why?
|
Infant, Newborn | 6 | 2020 | 1162 | 0.380 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 591 | 0.380 |
Why?
|
Adolescent | 15 | 2022 | 5324 | 0.380 |
Why?
|
Leadership | 2 | 2023 | 169 | 0.370 |
Why?
|
Quality of Health Care | 4 | 2012 | 471 | 0.370 |
Why?
|
Violence | 2 | 2009 | 154 | 0.370 |
Why?
|
Influenza Vaccines | 2 | 2014 | 88 | 0.360 |
Why?
|
Psychiatry | 3 | 2005 | 116 | 0.360 |
Why?
|
Databases, Factual | 4 | 2019 | 717 | 0.360 |
Why?
|
Recurrence | 5 | 2017 | 496 | 0.360 |
Why?
|
Neovascularization, Physiologic | 2 | 2000 | 102 | 0.360 |
Why?
|
Child, Preschool | 5 | 2023 | 1707 | 0.360 |
Why?
|
Trazodone | 1 | 2008 | 3 | 0.350 |
Why?
|
Central Nervous System Depressants | 1 | 2008 | 29 | 0.350 |
Why?
|
Evidence-Based Practice | 2 | 2023 | 68 | 0.350 |
Why?
|
Health Care Surveys | 7 | 2013 | 266 | 0.340 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2022 | 501 | 0.340 |
Why?
|
Risk-Taking | 8 | 2013 | 155 | 0.340 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2008 | 18 | 0.340 |
Why?
|
Regression Analysis | 8 | 2011 | 457 | 0.330 |
Why?
|
Polycythemia | 1 | 2007 | 4 | 0.330 |
Why?
|
Interviews as Topic | 5 | 2012 | 422 | 0.330 |
Why?
|
Health Care Reform | 2 | 2019 | 78 | 0.320 |
Why?
|
Program Evaluation | 5 | 2019 | 463 | 0.320 |
Why?
|
Ischemia | 4 | 2000 | 164 | 0.320 |
Why?
|
Follow-Up Studies | 12 | 2017 | 1936 | 0.310 |
Why?
|
Outpatients | 3 | 2017 | 114 | 0.310 |
Why?
|
Hallucinogens | 1 | 2006 | 12 | 0.310 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2006 | 19 | 0.300 |
Why?
|
Risk Factors | 16 | 2012 | 4248 | 0.300 |
Why?
|
Time Factors | 9 | 2017 | 3127 | 0.300 |
Why?
|
Social Security | 1 | 2006 | 6 | 0.300 |
Why?
|
Anemia | 1 | 2007 | 107 | 0.300 |
Why?
|
Oxycodone | 1 | 2006 | 31 | 0.300 |
Why?
|
Case Management | 2 | 2004 | 52 | 0.300 |
Why?
|
United States Department of Veterans Affairs | 5 | 2014 | 396 | 0.300 |
Why?
|
Antidepressive Agents | 2 | 2010 | 212 | 0.300 |
Why?
|
Preventive Health Services | 3 | 2012 | 73 | 0.290 |
Why?
|
Pregnancy Complications | 3 | 2019 | 380 | 0.290 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 98 | 0.290 |
Why?
|
Ethanol | 1 | 2008 | 236 | 0.290 |
Why?
|
Rehabilitation, Vocational | 1 | 2005 | 35 | 0.290 |
Why?
|
Internal Medicine | 5 | 2005 | 144 | 0.290 |
Why?
|
Health Surveys | 3 | 2006 | 309 | 0.280 |
Why?
|
Cocaine-Related Disorders | 1 | 2006 | 66 | 0.280 |
Why?
|
Drug Utilization | 2 | 2005 | 215 | 0.270 |
Why?
|
Surgery Department, Hospital | 2 | 1998 | 18 | 0.270 |
Why?
|
Health Services for the Aged | 2 | 2004 | 44 | 0.270 |
Why?
|
Hospitals, Community | 2 | 2019 | 62 | 0.270 |
Why?
|
Substance Withdrawal Syndrome | 4 | 2020 | 95 | 0.270 |
Why?
|
Sex Factors | 7 | 2013 | 852 | 0.260 |
Why?
|
Motivational Interviewing | 2 | 2022 | 37 | 0.260 |
Why?
|
Child | 4 | 2021 | 3791 | 0.260 |
Why?
|
Odds Ratio | 7 | 2014 | 755 | 0.260 |
Why?
|
Prevalence | 6 | 2010 | 1121 | 0.260 |
Why?
|
Comprehensive Health Care | 1 | 2004 | 20 | 0.260 |
Why?
|
Internship and Residency | 5 | 1998 | 590 | 0.250 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 41 | 0.250 |
Why?
|
Social Stigma | 2 | 2023 | 43 | 0.250 |
Why?
|
Disabled Persons | 1 | 2006 | 181 | 0.240 |
Why?
|
Medically Uninsured | 2 | 2019 | 45 | 0.240 |
Why?
|
Health Behavior | 3 | 2002 | 465 | 0.240 |
Why?
|
Mental Processes | 1 | 2023 | 14 | 0.240 |
Why?
|
Syringes | 1 | 2023 | 8 | 0.240 |
Why?
|
Vascular Surgical Procedures | 4 | 1993 | 219 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2012 | 729 | 0.240 |
Why?
|
Connecticut | 2 | 2013 | 82 | 0.240 |
Why?
|
Hypnotics and Sedatives | 1 | 2003 | 48 | 0.230 |
Why?
|
Preoperative Care | 4 | 2007 | 141 | 0.230 |
Why?
|
Methamphetamine | 1 | 2022 | 24 | 0.230 |
Why?
|
Patient Selection | 3 | 2017 | 354 | 0.230 |
Why?
|
Federal Government | 2 | 2017 | 17 | 0.230 |
Why?
|
Prescription Drug Diversion | 1 | 2022 | 7 | 0.230 |
Why?
|
Drug Utilization Review | 2 | 1999 | 57 | 0.230 |
Why?
|
Vaccination | 1 | 2004 | 267 | 0.220 |
Why?
|
Friends | 1 | 2022 | 26 | 0.220 |
Why?
|
Influenza, Human | 1 | 2004 | 195 | 0.220 |
Why?
|
Safe Sex | 1 | 2001 | 25 | 0.220 |
Why?
|
Transportation of Patients | 1 | 2001 | 24 | 0.210 |
Why?
|
Hepacivirus | 1 | 2023 | 130 | 0.210 |
Why?
|
Guideline Adherence | 4 | 2014 | 267 | 0.210 |
Why?
|
Binge Drinking | 1 | 2021 | 23 | 0.210 |
Why?
|
Health Services Research | 4 | 2013 | 252 | 0.210 |
Why?
|
Activities of Daily Living | 2 | 1999 | 269 | 0.210 |
Why?
|
Medical History Taking | 1 | 2001 | 50 | 0.210 |
Why?
|
Endarterectomy | 4 | 1989 | 18 | 0.200 |
Why?
|
Residential Treatment | 2 | 2019 | 24 | 0.200 |
Why?
|
Coercion | 2 | 2016 | 41 | 0.200 |
Why?
|
Cocaine | 4 | 2012 | 74 | 0.200 |
Why?
|
Smoking | 3 | 2014 | 741 | 0.200 |
Why?
|
Guilt | 1 | 2020 | 8 | 0.200 |
Why?
|
Shame | 1 | 2020 | 7 | 0.200 |
Why?
|
Feasibility Studies | 5 | 2013 | 429 | 0.200 |
Why?
|
Health Equity | 1 | 2020 | 27 | 0.200 |
Why?
|
Needs Assessment | 1 | 2001 | 159 | 0.190 |
Why?
|
Mortality | 1 | 2001 | 144 | 0.190 |
Why?
|
Antiviral Agents | 2 | 2013 | 292 | 0.190 |
Why?
|
Linear Models | 5 | 2012 | 409 | 0.190 |
Why?
|
Judgment | 1 | 2020 | 27 | 0.190 |
Why?
|
Hospitals, Teaching | 2 | 1992 | 97 | 0.190 |
Why?
|
Risk Assessment | 4 | 2011 | 1574 | 0.190 |
Why?
|
Hospitals, Veterans | 2 | 2012 | 147 | 0.190 |
Why?
|
Sickness Impact Profile | 1 | 1999 | 32 | 0.190 |
Why?
|
Emergencies | 2 | 1999 | 92 | 0.190 |
Why?
|
Vermont | 1 | 2019 | 16 | 0.190 |
Why?
|
Ambulatory Care Facilities | 1 | 2000 | 97 | 0.190 |
Why?
|
Cost Allocation | 1 | 2019 | 2 | 0.190 |
Why?
|
New Hampshire | 1 | 2019 | 39 | 0.190 |
Why?
|
Graft Survival | 2 | 2017 | 234 | 0.190 |
Why?
|
Postpartum Period | 1 | 2021 | 172 | 0.180 |
Why?
|
Pandemics | 2 | 2021 | 451 | 0.180 |
Why?
|
Communication | 2 | 2023 | 442 | 0.180 |
Why?
|
Statistics as Topic | 4 | 2014 | 141 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 128 | 0.180 |
Why?
|
Carotid Arteries | 2 | 1989 | 56 | 0.180 |
Why?
|
Cardiology | 2 | 1997 | 78 | 0.180 |
Why?
|
Medication Errors | 1 | 1999 | 109 | 0.180 |
Why?
|
Decision Making | 2 | 2019 | 321 | 0.180 |
Why?
|
Focus Groups | 1 | 2020 | 258 | 0.180 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 1995 | 58 | 0.180 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 27 | 0.180 |
Why?
|
Analysis of Variance | 8 | 2008 | 536 | 0.180 |
Why?
|
Maternal Health Services | 1 | 2019 | 55 | 0.180 |
Why?
|
Professional-Patient Relations | 1 | 2020 | 146 | 0.170 |
Why?
|
Buprenorphine, Naloxone Drug Combination | 3 | 2013 | 19 | 0.170 |
Why?
|
Betacoronavirus | 1 | 2020 | 152 | 0.170 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 74 | 0.170 |
Why?
|
Health Insurance Exchanges | 1 | 2017 | 1 | 0.170 |
Why?
|
Breast Feeding | 1 | 2020 | 121 | 0.170 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 1998 | 9 | 0.170 |
Why?
|
Interprofessional Relations | 2 | 2012 | 126 | 0.170 |
Why?
|
Pain Management | 1 | 2019 | 121 | 0.170 |
Why?
|
Public Policy | 1 | 2018 | 27 | 0.170 |
Why?
|
Polytetrafluoroethylene | 1 | 1997 | 17 | 0.160 |
Why?
|
Risk Management | 1 | 1998 | 46 | 0.160 |
Why?
|
Psychotic Disorders | 2 | 2012 | 135 | 0.160 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1998 | 153 | 0.160 |
Why?
|
Patient Preference | 1 | 2018 | 66 | 0.160 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 131 | 0.160 |
Why?
|
Patient Participation | 1 | 2019 | 185 | 0.160 |
Why?
|
Surgical Wound Infection | 1 | 1998 | 74 | 0.160 |
Why?
|
Survival Rate | 3 | 2019 | 656 | 0.160 |
Why?
|
Wounds and Injuries | 1 | 1999 | 209 | 0.160 |
Why?
|
Donor Selection | 1 | 2017 | 18 | 0.160 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 1997 | 37 | 0.160 |
Why?
|
Alcoholic Intoxication | 1 | 2017 | 21 | 0.160 |
Why?
|
Coronavirus Infections | 1 | 2020 | 175 | 0.160 |
Why?
|
Urban Population | 7 | 2008 | 187 | 0.160 |
Why?
|
Schizophrenia | 2 | 2012 | 215 | 0.160 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 187 | 0.160 |
Why?
|
Patient Readmission | 1 | 2001 | 353 | 0.160 |
Why?
|
Combined Modality Therapy | 5 | 1999 | 300 | 0.160 |
Why?
|
Patient Care Management | 1 | 2017 | 27 | 0.160 |
Why?
|
Physician's Role | 1 | 1998 | 119 | 0.160 |
Why?
|
Organizational Innovation | 1 | 2017 | 75 | 0.150 |
Why?
|
Cross Infection | 1 | 1998 | 125 | 0.150 |
Why?
|
Incidence | 5 | 2011 | 1122 | 0.150 |
Why?
|
Bipolar Disorder | 2 | 2012 | 243 | 0.150 |
Why?
|
Diabetic Angiopathies | 3 | 2009 | 28 | 0.150 |
Why?
|
Patient Care Team | 1 | 1999 | 275 | 0.150 |
Why?
|
Organizations | 1 | 2016 | 3 | 0.150 |
Why?
|
Chicago | 3 | 2001 | 26 | 0.150 |
Why?
|
Clinical Protocols | 1 | 2017 | 116 | 0.150 |
Why?
|
Postoperative Care | 1 | 1996 | 85 | 0.150 |
Why?
|
Meningitis | 1 | 1995 | 9 | 0.150 |
Why?
|
Endarterectomy, Carotid | 1 | 1996 | 69 | 0.150 |
Why?
|
Biocompatible Materials | 1 | 1997 | 128 | 0.150 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 234 | 0.150 |
Why?
|
Social Support | 2 | 2013 | 335 | 0.150 |
Why?
|
Kidney Transplantation | 1 | 2017 | 171 | 0.150 |
Why?
|
Renal Dialysis | 1 | 1997 | 167 | 0.150 |
Why?
|
Human Experimentation | 1 | 2016 | 37 | 0.150 |
Why?
|
Contract Services | 1 | 2015 | 2 | 0.140 |
Why?
|
Diabetes Complications | 2 | 2011 | 103 | 0.140 |
Why?
|
Methylprednisolone | 1 | 1995 | 21 | 0.140 |
Why?
|
Neovascularization, Pathologic | 2 | 1995 | 118 | 0.140 |
Why?
|
Patient Admission | 1 | 2017 | 163 | 0.140 |
Why?
|
Patient Education as Topic | 3 | 2014 | 438 | 0.140 |
Why?
|
Spinal Cord Injuries | 1 | 1995 | 22 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2006 | 126 | 0.140 |
Why?
|
Ureteral Neoplasms | 1 | 1995 | 2 | 0.140 |
Why?
|
Intersectoral Collaboration | 1 | 2015 | 16 | 0.140 |
Why?
|
Safety-net Providers | 1 | 2015 | 25 | 0.140 |
Why?
|
Community-Institutional Relations | 1 | 2015 | 37 | 0.140 |
Why?
|
Survival Analysis | 4 | 2012 | 473 | 0.140 |
Why?
|
Body Weight | 1 | 2017 | 384 | 0.140 |
Why?
|
Carcinoma | 2 | 1987 | 112 | 0.140 |
Why?
|
Fibroblast Growth Factors | 1 | 1995 | 57 | 0.140 |
Why?
|
Taurine | 1 | 2014 | 3 | 0.140 |
Why?
|
Ureter | 1 | 1995 | 20 | 0.140 |
Why?
|
Disulfiram | 1 | 2014 | 3 | 0.140 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 951 | 0.140 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 1996 | 124 | 0.130 |
Why?
|
Spinal Cord | 1 | 1995 | 132 | 0.130 |
Why?
|
Accountable Care Organizations | 1 | 2015 | 32 | 0.130 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 378 | 0.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1995 | 42 | 0.130 |
Why?
|
Pneumococcal Vaccines | 1 | 2014 | 16 | 0.130 |
Why?
|
Aftercare | 2 | 2022 | 64 | 0.130 |
Why?
|
Directive Counseling | 1 | 2014 | 41 | 0.130 |
Why?
|
Elective Surgical Procedures | 2 | 2022 | 103 | 0.130 |
Why?
|
Inpatients | 1 | 2017 | 258 | 0.130 |
Why?
|
Recombinant Proteins | 2 | 2013 | 641 | 0.130 |
Why?
|
Smoking Prevention | 2 | 2013 | 184 | 0.130 |
Why?
|
Smoke-Free Policy | 1 | 2013 | 8 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2014 | 53 | 0.130 |
Why?
|
Tobacco Products | 1 | 2014 | 44 | 0.130 |
Why?
|
History, 19th Century | 3 | 2001 | 55 | 0.120 |
Why?
|
Ribavirin | 1 | 2013 | 25 | 0.120 |
Why?
|
Education, Pharmacy, Continuing | 1 | 2013 | 3 | 0.120 |
Why?
|
Personal Autonomy | 1 | 2013 | 64 | 0.120 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 55 | 0.120 |
Why?
|
Interferon-alpha | 1 | 2013 | 93 | 0.120 |
Why?
|
Physician-Patient Relations | 3 | 2002 | 344 | 0.120 |
Why?
|
Collateral Circulation | 1 | 1992 | 19 | 0.120 |
Why?
|
Viral Load | 1 | 2013 | 225 | 0.120 |
Why?
|
Specialization | 2 | 2005 | 66 | 0.120 |
Why?
|
Electronic Prescribing | 1 | 2012 | 11 | 0.120 |
Why?
|
History, 20th Century | 3 | 2001 | 211 | 0.120 |
Why?
|
Polyethylene Glycols | 1 | 2013 | 161 | 0.110 |
Why?
|
Administration, Oral | 1 | 2013 | 301 | 0.110 |
Why?
|
Total Quality Management | 1 | 1992 | 46 | 0.110 |
Why?
|
Program Development | 3 | 2008 | 208 | 0.110 |
Why?
|
Heart Failure | 2 | 2014 | 656 | 0.110 |
Why?
|
Intensive Care Units | 2 | 1996 | 334 | 0.110 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 69 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2012 | 46 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2014 | 722 | 0.110 |
Why?
|
Cause of Death | 1 | 2012 | 172 | 0.110 |
Why?
|
Lens Capsule, Crystalline | 1 | 2011 | 2 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2013 | 1312 | 0.110 |
Why?
|
Tuberculosis | 3 | 2000 | 229 | 0.110 |
Why?
|
Lacerations | 1 | 2011 | 11 | 0.110 |
Why?
|
Vitreous Body | 1 | 2011 | 18 | 0.100 |
Why?
|
Interview, Psychological | 2 | 2009 | 75 | 0.100 |
Why?
|
Accreditation | 2 | 2007 | 56 | 0.100 |
Why?
|
Mandatory Programs | 1 | 2011 | 16 | 0.100 |
Why?
|
Cataract | 1 | 2011 | 44 | 0.100 |
Why?
|
Hospital Departments | 1 | 1990 | 17 | 0.100 |
Why?
|
Crack Cocaine | 3 | 1997 | 7 | 0.100 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2008 | 119 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2012 | 133 | 0.100 |
Why?
|
Erectile Dysfunction | 1 | 2010 | 18 | 0.100 |
Why?
|
Streptonigrin | 1 | 2010 | 3 | 0.100 |
Why?
|
Hospitals, University | 2 | 2001 | 48 | 0.100 |
Why?
|
Transportation | 2 | 2001 | 31 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2010 | 549 | 0.100 |
Why?
|
Citalopram | 1 | 2010 | 16 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 1988 | 329 | 0.100 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 750 | 0.100 |
Why?
|
Postoperative Period | 1 | 2010 | 101 | 0.100 |
Why?
|
Medicine | 1 | 1990 | 48 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2019 | 755 | 0.100 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2012 | 173 | 0.100 |
Why?
|
Testosterone | 1 | 2010 | 125 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 250 | 0.100 |
Why?
|
Periodicals as Topic | 1 | 2012 | 161 | 0.100 |
Why?
|
Tuberculin Test | 2 | 2000 | 11 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 1990 | 116 | 0.090 |
Why?
|
Long-Term Care | 1 | 2010 | 155 | 0.090 |
Why?
|
Appointments and Schedules | 1 | 2009 | 39 | 0.090 |
Why?
|
Hemodynamics | 1 | 1990 | 177 | 0.090 |
Why?
|
Models, Organizational | 3 | 2015 | 85 | 0.090 |
Why?
|
Unsafe Sex | 1 | 2009 | 28 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2012 | 627 | 0.090 |
Why?
|
Skin | 3 | 2006 | 317 | 0.090 |
Why?
|
Inactivation, Metabolic | 1 | 2008 | 12 | 0.090 |
Why?
|
Macular Degeneration | 1 | 2011 | 148 | 0.090 |
Why?
|
New York City | 9 | 2000 | 73 | 0.090 |
Why?
|
Societies, Medical | 2 | 2001 | 215 | 0.090 |
Why?
|
Internal-External Control | 1 | 2008 | 38 | 0.080 |
Why?
|
Verbal Behavior | 1 | 2008 | 29 | 0.080 |
Why?
|
AIDS Serodiagnosis | 2 | 2002 | 18 | 0.080 |
Why?
|
Antisocial Personality Disorder | 1 | 2008 | 34 | 0.080 |
Why?
|
HIV Seroprevalence | 3 | 1996 | 9 | 0.080 |
Why?
|
Radiation Injuries | 1 | 1988 | 49 | 0.080 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 2 | 2000 | 4 | 0.080 |
Why?
|
Intestine, Large | 1 | 1987 | 5 | 0.080 |
Why?
|
Life Tables | 2 | 1997 | 26 | 0.080 |
Why?
|
Cost Control | 1 | 2007 | 18 | 0.080 |
Why?
|
Community Networks | 1 | 2007 | 30 | 0.080 |
Why?
|
Staff Development | 1 | 2007 | 51 | 0.080 |
Why?
|
Professional Practice | 1 | 2006 | 26 | 0.080 |
Why?
|
Educational Status | 1 | 2008 | 258 | 0.080 |
Why?
|
Drug Prescriptions | 2 | 2006 | 177 | 0.080 |
Why?
|
Rabbits | 2 | 2000 | 302 | 0.080 |
Why?
|
Risk | 1 | 2007 | 362 | 0.080 |
Why?
|
Confidence Intervals | 2 | 2011 | 256 | 0.080 |
Why?
|
Drug Interactions | 2 | 2012 | 98 | 0.070 |
Why?
|
Organizational Culture | 1 | 2007 | 102 | 0.070 |
Why?
|
Medical Records | 1 | 2006 | 133 | 0.070 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2006 | 5 | 0.070 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2006 | 34 | 0.070 |
Why?
|
Eligibility Determination | 1 | 2006 | 28 | 0.070 |
Why?
|
Cues | 1 | 2006 | 58 | 0.070 |
Why?
|
Confidentiality | 2 | 2003 | 55 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 186 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2006 | 44 | 0.070 |
Why?
|
Medical Audit | 1 | 2006 | 55 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 2 | 1998 | 496 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 358 | 0.070 |
Why?
|
Attitude to Health | 1 | 2008 | 292 | 0.070 |
Why?
|
Depression | 2 | 2010 | 748 | 0.070 |
Why?
|
Sleep Stages | 1 | 2005 | 21 | 0.070 |
Why?
|
Injections | 2 | 2018 | 71 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 2 | 1976 | 58 | 0.070 |
Why?
|
Femoral Artery | 3 | 1988 | 73 | 0.070 |
Why?
|
Plant Preparations | 1 | 2005 | 17 | 0.070 |
Why?
|
Epidermolysis Bullosa | 1 | 2004 | 7 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2000 | 576 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2006 | 178 | 0.070 |
Why?
|
Gynecology | 2 | 2005 | 50 | 0.070 |
Why?
|
Cannabinoids | 1 | 2005 | 25 | 0.070 |
Why?
|
Mucin-1 | 1 | 2004 | 11 | 0.070 |
Why?
|
Diagnosis, Dual (Psychiatry) | 2 | 2009 | 78 | 0.070 |
Why?
|
Women's Health | 1 | 2008 | 392 | 0.070 |
Why?
|
Sleep Apnea Syndromes | 1 | 2005 | 26 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 1996 | 245 | 0.070 |
Why?
|
Cannabis | 1 | 2005 | 29 | 0.070 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2005 | 44 | 0.070 |
Why?
|
Phytotherapy | 1 | 2005 | 54 | 0.070 |
Why?
|
Popliteal Artery | 2 | 1976 | 18 | 0.070 |
Why?
|
Housing | 1 | 2004 | 53 | 0.060 |
Why?
|
Obstetrics | 2 | 2005 | 70 | 0.060 |
Why?
|
Decision Trees | 1 | 2003 | 45 | 0.060 |
Why?
|
Drug Combinations | 2 | 2012 | 119 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2011 | 1143 | 0.060 |
Why?
|
Refusal to Treat | 1 | 2003 | 2 | 0.060 |
Why?
|
Uncompensated Care | 1 | 2003 | 3 | 0.060 |
Why?
|
Laboratories, Hospital | 1 | 2003 | 9 | 0.060 |
Why?
|
Halfway Houses | 1 | 2003 | 2 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2003 | 66 | 0.060 |
Why?
|
Waiting Lists | 1 | 2003 | 43 | 0.060 |
Why?
|
Rats | 2 | 1998 | 1676 | 0.060 |
Why?
|
Convalescence | 1 | 2003 | 16 | 0.060 |
Why?
|
House Calls | 1 | 2023 | 15 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2009 | 606 | 0.060 |
Why?
|
Community Mental Health Centers | 1 | 2003 | 22 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2004 | 140 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2006 | 241 | 0.060 |
Why?
|
Managed Care Programs | 1 | 2003 | 79 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2004 | 325 | 0.060 |
Why?
|
Contrast Media | 2 | 1995 | 293 | 0.060 |
Why?
|
Occupational Health Services | 1 | 2003 | 42 | 0.060 |
Why?
|
Grounded Theory | 1 | 2022 | 16 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 269 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 256 | 0.060 |
Why?
|
Habits | 1 | 2022 | 22 | 0.060 |
Why?
|
Parenting | 1 | 2023 | 68 | 0.060 |
Why?
|
Interpersonal Relations | 2 | 2001 | 138 | 0.060 |
Why?
|
Curriculum | 1 | 2005 | 496 | 0.060 |
Why?
|
Geriatric Assessment | 1 | 2003 | 151 | 0.050 |
Why?
|
Animals | 6 | 2000 | 17732 | 0.050 |
Why?
|
Workplace | 1 | 2003 | 182 | 0.050 |
Why?
|
Episode of Care | 1 | 2001 | 9 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2001 | 47 | 0.050 |
Why?
|
Poverty Areas | 1 | 2001 | 15 | 0.050 |
Why?
|
Poverty | 1 | 2003 | 283 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2003 | 258 | 0.050 |
Why?
|
Specialty Boards | 2 | 1990 | 12 | 0.050 |
Why?
|
Factor Analysis, Statistical | 2 | 2013 | 101 | 0.050 |
Why?
|
Certification | 2 | 1990 | 36 | 0.050 |
Why?
|
Nurses | 1 | 2021 | 82 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2001 | 89 | 0.050 |
Why?
|
Cardiac Rehabilitation | 1 | 2021 | 52 | 0.050 |
Why?
|
Social Work | 1 | 2000 | 19 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 1996 | 372 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2000 | 87 | 0.050 |
Why?
|
Quality Indicators, Health Care | 2 | 2014 | 312 | 0.050 |
Why?
|
Peptic Ulcer | 1 | 1999 | 22 | 0.050 |
Why?
|
Schools, Medical | 1 | 2001 | 136 | 0.050 |
Why?
|
Respiratory Tract Diseases | 1 | 1999 | 28 | 0.050 |
Why?
|
Radiotherapy Dosage | 2 | 1996 | 68 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2004 | 349 | 0.050 |
Why?
|
Research Design | 3 | 2011 | 528 | 0.050 |
Why?
|
Histamine Antagonists | 1 | 1999 | 8 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2003 | 209 | 0.050 |
Why?
|
Morbidity | 1 | 1999 | 90 | 0.050 |
Why?
|
Psychometrics | 2 | 2014 | 347 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2006 | 501 | 0.050 |
Why?
|
Perioperative Period | 1 | 2019 | 16 | 0.050 |
Why?
|
Streptozocin | 1 | 1998 | 13 | 0.040 |
Why?
|
Patient Discharge | 1 | 2022 | 423 | 0.040 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1998 | 8 | 0.040 |
Why?
|
Accidental Falls | 1 | 1999 | 130 | 0.040 |
Why?
|
Self-Help Groups | 1 | 1998 | 40 | 0.040 |
Why?
|
Income | 1 | 2019 | 147 | 0.040 |
Why?
|
Forearm | 1 | 1997 | 17 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2015 | 214 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 1997 | 64 | 0.040 |
Why?
|
Angiography | 2 | 1974 | 120 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 1995 | 1787 | 0.040 |
Why?
|
Vascular Patency | 1 | 1997 | 127 | 0.040 |
Why?
|
Benchmarking | 1 | 1998 | 118 | 0.040 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 1 | 0.040 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 5 | 0.040 |
Why?
|
Spermatozoa | 1 | 1998 | 250 | 0.040 |
Why?
|
Thailand | 5 | 1995 | 101 | 0.040 |
Why?
|
Mental Health | 1 | 1999 | 289 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 106 | 0.040 |
Why?
|
Anemia, Sickle Cell | 1 | 1997 | 65 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1996 | 55 | 0.040 |
Why?
|
Physicians | 1 | 2021 | 380 | 0.040 |
Why?
|
Condoms | 2 | 1993 | 48 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 1996 | 34 | 0.040 |
Why?
|
Hospital Costs | 1 | 1997 | 95 | 0.040 |
Why?
|
Heroin | 2 | 1997 | 11 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 1978 | 194 | 0.040 |
Why?
|
Angina Pectoris | 1 | 1996 | 40 | 0.040 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 1995 | 4 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 1996 | 177 | 0.040 |
Why?
|
Spinal Puncture | 1 | 1995 | 14 | 0.040 |
Why?
|
Safety | 1 | 1996 | 129 | 0.040 |
Why?
|
Economic Competition | 1 | 2015 | 7 | 0.040 |
Why?
|
Ownership | 1 | 2015 | 9 | 0.040 |
Why?
|
Saphenous Vein | 2 | 1976 | 52 | 0.040 |
Why?
|
Hypercholesterolemia | 1 | 1996 | 68 | 0.040 |
Why?
|
Systems Integration | 1 | 2015 | 25 | 0.040 |
Why?
|
Hypertension, Renal | 1 | 1995 | 5 | 0.040 |
Why?
|
Behavior | 1 | 1995 | 38 | 0.040 |
Why?
|
Pentetic Acid | 1 | 1995 | 26 | 0.030 |
Why?
|
Drug Synergism | 1 | 1995 | 119 | 0.030 |
Why?
|
Meglumine | 1 | 1995 | 16 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1995 | 163 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 1995 | 65 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 1995 | 62 | 0.030 |
Why?
|
Gadolinium | 1 | 1995 | 54 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 1995 | 59 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 2 | 1976 | 170 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 1995 | 123 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 1995 | 359 | 0.030 |
Why?
|
Movement | 1 | 1995 | 131 | 0.030 |
Why?
|
Hospitals | 1 | 1997 | 296 | 0.030 |
Why?
|
Coronary Disease | 1 | 1996 | 297 | 0.030 |
Why?
|
Motivation | 1 | 2016 | 240 | 0.030 |
Why?
|
History, 18th Century | 1 | 1993 | 10 | 0.030 |
Why?
|
History, Ancient | 1 | 1993 | 15 | 0.030 |
Why?
|
Health Facility Administrators | 1 | 2013 | 7 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2014 | 120 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 1996 | 288 | 0.030 |
Why?
|
Didanosine | 1 | 1992 | 3 | 0.030 |
Why?
|
Zidovudine | 1 | 1992 | 12 | 0.030 |
Why?
|
Clinical Competence | 1 | 1997 | 544 | 0.030 |
Why?
|
Ventricular Function, Left | 1 | 2014 | 178 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 1993 | 66 | 0.030 |
Why?
|
Tetrazolium Salts | 1 | 1992 | 13 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1992 | 25 | 0.030 |
Why?
|
Ligation | 1 | 1992 | 25 | 0.030 |
Why?
|
Washington | 1 | 2012 | 36 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2015 | 278 | 0.030 |
Why?
|
Prothrombin Time | 1 | 2012 | 5 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2012 | 7 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2012 | 102 | 0.030 |
Why?
|
Bevacizumab | 1 | 2012 | 28 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 1985 | 58 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 69 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 284 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2012 | 72 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2012 | 81 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 1992 | 58 | 0.030 |
Why?
|
Radiography | 1 | 1992 | 341 | 0.030 |
Why?
|
Pulmonary Wedge Pressure | 1 | 1990 | 17 | 0.030 |
Why?
|
Health Education | 2 | 2008 | 191 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1990 | 36 | 0.030 |
Why?
|
Hypertension | 1 | 1996 | 542 | 0.030 |
Why?
|
Cardiac Output | 1 | 1990 | 34 | 0.030 |
Why?
|
Acute Disease | 1 | 1992 | 604 | 0.030 |
Why?
|
Surgery, Plastic | 1 | 1990 | 11 | 0.020 |
Why?
|
Specialties, Surgical | 1 | 1990 | 27 | 0.020 |
Why?
|
Thoracic Surgery | 1 | 1990 | 30 | 0.020 |
Why?
|
Teaching | 1 | 1990 | 150 | 0.020 |
Why?
|
National Institute on Drug Abuse (U.S.) | 1 | 2009 | 2 | 0.020 |
Why?
|
Educational Measurement | 1 | 1990 | 176 | 0.020 |
Why?
|
Coumarins | 1 | 1988 | 6 | 0.020 |
Why?
|
HIV-1 | 1 | 1994 | 677 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1988 | 62 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2003 | 821 | 0.020 |
Why?
|
Iodine Isotopes | 1 | 1968 | 2 | 0.020 |
Why?
|
Hyperthyroidism | 1 | 1968 | 15 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 1988 | 50 | 0.020 |
Why?
|
Financial Support | 1 | 2008 | 3 | 0.020 |
Why?
|
Necrosis | 1 | 1988 | 115 | 0.020 |
Why?
|
Heparin | 1 | 1988 | 96 | 0.020 |
Why?
|
Renal Veins | 1 | 1987 | 7 | 0.020 |
Why?
|
Psychology | 1 | 2008 | 47 | 0.020 |
Why?
|
Heart Diseases | 1 | 2009 | 168 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 1995 | 1378 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 1988 | 82 | 0.020 |
Why?
|
Arteriovenous Fistula | 1 | 1987 | 9 | 0.020 |
Why?
|
Demography | 1 | 2008 | 163 | 0.020 |
Why?
|
Surgical Staplers | 1 | 1987 | 6 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 1987 | 55 | 0.020 |
Why?
|
Pediatrics | 1 | 1990 | 249 | 0.020 |
Why?
|
Colostomy | 1 | 1987 | 9 | 0.020 |
Why?
|
Lipids | 1 | 2009 | 290 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 1988 | 199 | 0.020 |
Why?
|
Health Promotion | 1 | 2011 | 482 | 0.020 |
Why?
|
Universities | 1 | 2008 | 126 | 0.020 |
Why?
|
Suture Techniques | 1 | 1987 | 66 | 0.020 |
Why?
|
Celecoxib | 1 | 2006 | 15 | 0.020 |
Why?
|
England | 1 | 2006 | 16 | 0.020 |
Why?
|
Sulfones | 1 | 2006 | 31 | 0.020 |
Why?
|
Lactones | 1 | 2006 | 23 | 0.020 |
Why?
|
Dogs | 1 | 1987 | 285 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2006 | 82 | 0.020 |
Why?
|
Students | 1 | 2008 | 197 | 0.020 |
Why?
|
American Heart Association | 1 | 2006 | 84 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2006 | 114 | 0.020 |
Why?
|
Pyrazoles | 1 | 2006 | 59 | 0.020 |
Why?
|
Permissiveness | 1 | 2005 | 1 | 0.020 |
Why?
|
Pyridines | 1 | 2006 | 95 | 0.020 |
Why?
|
Leg | 2 | 1976 | 76 | 0.020 |
Why?
|
Sulfonamides | 1 | 2006 | 115 | 0.020 |
Why?
|
Bowen's Disease | 1 | 2004 | 1 | 0.020 |
Why?
|
Morals | 1 | 2005 | 22 | 0.020 |
Why?
|
Brazil | 2 | 1995 | 74 | 0.020 |
Why?
|
Radiotherapy | 1 | 1985 | 46 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2004 | 99 | 0.020 |
Why?
|
Glycosylation | 1 | 2004 | 132 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2004 | 122 | 0.020 |
Why?
|
Blood Pressure | 1 | 2006 | 476 | 0.020 |
Why?
|
Information Services | 1 | 2002 | 37 | 0.010 |
Why?
|
Body Mass Index | 1 | 2006 | 852 | 0.010 |
Why?
|
Biomarkers | 1 | 2006 | 1002 | 0.010 |
Why?
|
Sigmoid Neoplasms | 1 | 1978 | 4 | 0.010 |
Why?
|
Skin Tests | 1 | 1997 | 16 | 0.010 |
Why?
|
Illinois | 1 | 1997 | 12 | 0.010 |
Why?
|
Marijuana Smoking | 1 | 1997 | 11 | 0.010 |
Why?
|
Hospital Charges | 1 | 1997 | 20 | 0.010 |
Why?
|
World Health Organization | 1 | 1996 | 29 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1995 | 29 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1976 | 95 | 0.010 |
Why?
|
Scotland | 1 | 1995 | 7 | 0.010 |
Why?
|
Drug Resistance, Multiple | 1 | 1995 | 32 | 0.010 |
Why?
|
Fever | 1 | 1995 | 65 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 1976 | 210 | 0.010 |
Why?
|
Graft Rejection | 1 | 1976 | 186 | 0.010 |
Why?
|
Self-Assessment | 1 | 1994 | 51 | 0.010 |
Why?
|
Personality Development | 1 | 1993 | 7 | 0.010 |
Why?
|
Child Abuse, Sexual | 1 | 1993 | 24 | 0.010 |
Why?
|
Child of Impaired Parents | 1 | 1993 | 26 | 0.010 |
Why?
|
Dangerous Behavior | 1 | 1993 | 20 | 0.010 |
Why?
|
Methods | 1 | 1972 | 37 | 0.010 |
Why?
|
Rehabilitation | 1 | 1991 | 5 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 1995 | 338 | 0.010 |
Why?
|
Prosthesis Design | 1 | 1972 | 156 | 0.010 |
Why?
|
Contraception | 1 | 1992 | 60 | 0.010 |
Why?
|
Prenatal Care | 1 | 1993 | 178 | 0.010 |
Why?
|
Polymers | 1 | 1972 | 278 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1988 | 66 | 0.010 |
Why?
|
Intermittent Claudication | 1 | 1988 | 37 | 0.010 |
Why?
|
Aorta | 1 | 1988 | 87 | 0.010 |
Why?
|
Hypothyroidism | 1 | 1968 | 30 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1987 | 73 | 0.000 |
Why?
|